Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Biallelic Mutations in Hamp in Type 2b Hemochromatosis

Serge Pissard, MDPhD, Ka Chandran, Florence Houriez, Ichrache Benmaad, Martial Saunier, Thibault Lefebvre, Patricia Aguilar-Martinez, MD PhD, Patricia A. Bignell, Gerald Le Gac, MDPhD, Jacques Rochette, MB, DSc

Blood (2016) 128 (22): 1279.

https://doi.org/10.1182/blood.V128.22.1279.1279

Published: 2016

Journal Articles

A Multinational, Open-Label Phase 2 Study Of Ruxolitinib In Asian Patients (Pts) With Primary Myelofibrosis (PMF), Post–Polycythemia Vera MF (PPV-MF), Or Post–Essential Thrombocythemia MF (PET-MF)

Chul Won Jung, MD, PhD, Lee-Yung Shih, MD, Zhijian Xiao, MD, Jie Jin, MD, Hsin-An Hou, MD, Xin Du, MD, Ming-Chung Wang, MD, Seonyang Park, MD, PhD, Ki-Seong Eom, MD, PhD, Kenji Oritani, Shinichiro Okamoto, MD, PhD, Tetsuzo Tauchi, MD, Jin Seok Kim, MD, Daobin Zhou, MD, Andres Sirulnik, MD, PhD, Wanda Ruiz, PhD, Taro Amagasaki, PhD, Kazuo Ito, Koichi Akashi, MD, PhD

Blood (2013) 122 (21): 4086.

https://doi.org/10.1182/blood.V122.21.4086.4086

Published: 2013

Journal Articles

Clarithromycin Enhances tyrosine Kinase Inhibitor – Induced Cell Death by Inhibition of Late Stage Autophagy in Patients with Chronic Myeloid Leukemia At Diagnosis or with Resistant Stage of Disease

A. M. Carella, MD, G. Beltrami, MD, G. Pica, MD, C. Ghiggi, MD, D. Lovera, MD, G. Cirmena, A. Garuti

Blood (2012) 120 (21): 3777.

https://doi.org/10.1182/blood.V120.21.3777.3777

Published: 2012

Journal Articles

Safety of Clofarabine with Multiagent Chemotherapy in Childhood High Risk Relapse of Acute Lymphoblastic Leukemia (Vandevol study of the French SFCE Acute Leukemia Committee).

Brigitte Nelken, MD, Guy Leverger, MD, Claire Galambrun, MD, Genevieve Plat, Claudine Schmitt, MD, Caroline Thomas, M.D., Cécile Vérité, MD, Benoit Brethon, MD, Virginie Gandemer, Yves Bertrand, André Baruchel, Pierre Rohrlich

Blood (2012) 120 (21): 2570.

https://doi.org/10.1182/blood.V120.21.2570.2570

Published: 2012

Journal Articles

Screening for Potential Covariates Influencing the Pharmacokinetics of Intravenous Busulfan: Results From a Large Pediatric Cohort Undergoing Hematopoietic Stem-Cell Transplantation

Zeinab Daher Abdi, Angelo Paci, PharmD, PhD, Despina Moshous, Jean-Hugues Dalle, MD, Nathalie Bleyzac, Benedicte Neven, Claire Galambrun, Véronique Kemmel, Aurélie Pétain, Sophie Broutin, Laurent Nguyen, Gilles Vassal

Blood (2010) 116 (21): 1811.

https://doi.org/10.1182/blood.V116.21.1811.1811

Published: 2010

NARROW

Biallelic Mutations in Hamp in Type 2b Hemochromatosis

A Multinational, Open-Label Phase 2 Study Of Ruxolitinib In Asian Patients (Pts) With Primary Myelofibrosis (PMF), Post–Polycythemia Vera MF (PPV-MF), Or Post–Essential Thrombocythemia MF (PET-MF)

Clarithromycin Enhances tyrosine Kinase Inhibitor – Induced Cell Death by Inhibition of Late Stage Autophagy in Patients with Chronic Myeloid Leukemia At Diagnosis or with Resistant Stage of Disease

Safety of Clofarabine with Multiagent Chemotherapy in Childhood High Risk Relapse of Acute Lymphoblastic Leukemia (Vandevol study of the French SFCE Acute Leukemia Committee).

Screening for Potential Covariates Influencing the Pharmacokinetics of Intravenous Busulfan: Results From a Large Pediatric Cohort Undergoing Hematopoietic Stem-Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Biallelic Mutations in Hamp in Type 2b Hemochromatosis

A Multinational, Open-Label Phase 2 Study Of Ruxolitinib In Asian Patients (Pts) With Primary Myelofibrosis (PMF), Post–Polycythemia Vera MF (PPV-MF), Or Post–Essential Thrombocythemia MF (PET-MF)

Clarithromycin Enhances tyrosine Kinase Inhibitor – Induced Cell Death by Inhibition of Late Stage Autophagy in Patients with Chronic Myeloid Leukemia At Diagnosis or with Resistant Stage of Disease

Safety of Clofarabine with Multiagent Chemotherapy in Childhood High Risk Relapse of Acute Lymphoblastic Leukemia (Vandevol study of the French SFCE Acute Leukemia Committee).

Screening for Potential Covariates Influencing the Pharmacokinetics of Intravenous Busulfan: Results From a Large Pediatric Cohort Undergoing Hematopoietic Stem-Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only